Metabolic biotinylation of lentiviral pseudotypes for scalable paramagnetic microparticle-dependent manipulation

TY - JOUR

T1 - Metabolic biotinylation of lentiviral pseudotypes for scalable paramagnetic microparticle-dependent manipulation

AU - Nesbeth, D

AU - Williams, S L

AU - Chan, Lucas

AU - Brain, T

AU - Slater, N K H

AU - Farzaneh, F

AU - Darling, D

PY - 2006/4

Y1 - 2006/4

N2 - Nonviral, host-derived proteins on lentiviral vector surfaces can have a profound effect on the vector's biology as they can both promote infection and provide resistance to complement inactivation. We have exploited this to engineer a specific posttranslational modification of a "nonenvelope," virally associated protein. The bacterial biotin ligase (BirA) and a modified human Delta LNGFR have been introduced into HEK293T cells and their protein products directed to the lumen of the endoplasmic reticulum. The BirA then couples biotin to an acceptor peptide that has been fused to the Delta LNGFR. This results in the covalent linkage of biotin to the extracellular domain of the Delta LNGFR expressed on the cell surface. Lentiviral vectors from these cells are metabolically labeled with biotin in the presence of free biotin. These biotinylated lentiviral vectors have a high affinity for streptavidin paramagnetic particles and, once captured, are easily manipulated in vitro. This is illustrated by the concentration of lentiviral vectors pseudotyped with either the VSV-G or an amphotropic envelope in excess of 4500-fold. This new cell line has the potential for widespread application to envelope pseudotypes compatible with lentiviral vector production

AB - Nonviral, host-derived proteins on lentiviral vector surfaces can have a profound effect on the vector's biology as they can both promote infection and provide resistance to complement inactivation. We have exploited this to engineer a specific posttranslational modification of a "nonenvelope," virally associated protein. The bacterial biotin ligase (BirA) and a modified human Delta LNGFR have been introduced into HEK293T cells and their protein products directed to the lumen of the endoplasmic reticulum. The BirA then couples biotin to an acceptor peptide that has been fused to the Delta LNGFR. This results in the covalent linkage of biotin to the extracellular domain of the Delta LNGFR expressed on the cell surface. Lentiviral vectors from these cells are metabolically labeled with biotin in the presence of free biotin. These biotinylated lentiviral vectors have a high affinity for streptavidin paramagnetic particles and, once captured, are easily manipulated in vitro. This is illustrated by the concentration of lentiviral vectors pseudotyped with either the VSV-G or an amphotropic envelope in excess of 4500-fold. This new cell line has the potential for widespread application to envelope pseudotypes compatible with lentiviral vector production

U2 - 10.1016/j.ymthe.2005.09.016

DO - 10.1016/j.ymthe.2005.09.016

M3 - Article

SN - 1525-0024

VL - 13

SP - 814

EP - 822

JO - Molecular Therapy

JF - Molecular Therapy

IS - 4

ER -